Emerging management and its impact on radioiodine refractory differentiated thyroid cancer / 中国实用外科杂志
Chinese Journal of Practical Surgery
; (12): 216-220, 2019.
Article
in Zh
| WPRIM
| ID: wpr-816372
Responsible library:
WPRO
ABSTRACT
Differentiated thyroid cancer(DTC) generally carries good prognosis through standard treatment. While,it could dedifferentiate into radioiodine refractory differentiated thyroid cancer(RAIR-DTC),which progresses rapidly with high mortality and limited treatment methods. Recently,along with the increasing of studies on genetic features,signal transduction pathways and immune microenvironment of RAIR-DTC,as well as the development of new radionuclide tracers,more theoretical bases have been provided for the targeted therapy of RAIR-DTC.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Practical Surgery
Year:
2019
Document type:
Article